Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia




Barkoff, Alex-Mikael; Kastrin, Tamara; Seme, Katja; Vitek, Marta Grgič; Mertsola, Jussi; He, Qiushui

PublisherCenters for Disease Control and Prevention (CDC)

2024

Emerging Infectious Diseases

Emerging Infectious Diseases

30

11

1080-6040

1080-6059

DOIhttps://doi.org/10.3201/eid3011.231393

http://doi.org/10.3201/eid3011.231393

https://research.utu.fi/converis/portal/detail/Publication/470941132



In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.


This study is partly supported by Tampere Tuberculosis Foundation (grant no. 26006205), Sigrid Juselius Foundation (grant no. 240045), and EUpertstrain project (project nos. 26004877 and 26004878).


Last updated on 2025-30-01 at 13:12